| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 0.983 | 120 | 0 | 1986 | 2020 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 0.983 | 117 | 0 | 1986 | 2020 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 1.000 | 30 | 0 | 1988 | 2019 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.100 | None | 0.900 | 20 | 1 | 2009 | 2019 | |||||||||
|
interferon, type 1, cluster | 0.565 | 0.731 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2005 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2010 | 2019 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2010 | 2019 | |||||||||
|
mannose-binding lectin family member 3, pseudogene | 0.518 | 0.769 |
|
disease | 0.100 | None | 0.800 | 10 | 0 | 1999 | 2014 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 1997 | 2017 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.080 | None | 0.875 | 8 | 0 | 2007 | 2019 | |||||||||
|
HTLV-1 related endogenous sequence | 0.636 | 0.615 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1995 | 2014 | |||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.060 | None | 0.833 | 6 | 1 | 2007 | 2019 | |||||||||
|
Hashimoto thyroiditis | 0.505 | 0.731 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2005 | 2020 | |||||||||
|
immunoglobulin heavy constant gamma 3 (G3m marker) | 0.513 | 0.769 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1996 | 2017 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2017 | |||||||||
|
microRNA 125a | 0.480 | 0.769 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2019 | |||||||||
|
Wegener granulomatosis | 0.595 | 0.808 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2002 | 2017 | |||||||||
|
platelet and endothelial cell adhesion molecule 1 | 0.426 | 0.846 |
|
disease | 0.050 | None | 1.000 | 5 | 2 | 1989 | 2019 | |||||||||
|
H4 clustered histone 15 | 0.541 | 0.692 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2018 | |||||||||
|
IgA nephropathy | 0.524 | 0.808 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2000 | 2017 | |||||||||
|
Myeloproliferative syndrome, transient (transient abnormal | 0.528 | 0.731 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2013 | 2019 | |||||||||
|
H4 clustered histone 14 | 0.541 | 0.692 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2018 | |||||||||
|
Fc fragment of IgG receptor IIc (gene/pseudogene) | 0.610 | 0.654 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1995 | 2013 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 | 0.599 | 0.615 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2007 | 2018 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2010 | 2017 |